Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EXEL · against 122 other Healthcare companies of similar size
Ranked #24 of 123 · scores higher than 81% of peers · safety percentile 71
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)11 peers with a safety percentile of 70–79, including EXEL · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | EXEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 119 reported | 0.09× | 0.39× | 81% | 33% | |
| BetaLower is better · 121 reported | 0.47 | 0.70 | 68% | 33% | |
| Current ratioHigher is better · 117 reported | 3.46× | 2.10× | 77% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 10.1B EUR (≈$11.1B) | 99 | ||
| 2 | 9.0B USD | 98 | 51 | |
| 3 | 10.2B USD | 97 | ||
| 4 | 9.8B USD | 96 | ||
| 5 | 26.0B USD | 93 | 28 | |
| 20 | 14.87T KRW (≈$10.7B) | 74 | 76 | |
| 21 | 23.8B USD | 74 | 84 | |
| 22 | 225.2B CNY (≈$31.5B) | 73 | 63 | |
| 23 | 13.7B USD | 72 | 45 | |
| 24 | 17.9B USD | 71 | 76 | |
| 25 | 13.9B EUR (≈$15.3B) | 69 | 78 | |
| 26 | 921.9B INR (≈$11.1B) | 68 | 82 | |
| 27 | 138.4B HKD (≈$17.7B) | 68 | 70 | |
| 28 | 177.2B HKD (≈$22.7B) | 68 | 73 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score